Financial insights of CSBR

MyFinsight

For the quarter ending 2026-01-31, CSBR made $16,559K in revenue. -$279K in net income. Net profit margin of -1.68%.

Income Statement	2026-01-31	2025-10-31	2025-07-31	2024-10-31
Oncology revenue	16,559	15,035	13,995	13,489
Cost of oncology revenue	8,834	7,262	7,995	7,428
Research and development	2,271	2,616	2,082	1,689
Sales and marketing	2,666	1,998	1,855	1,751
General and administrative	2,975	2,974	2,570	1,889
Loss on sale and disposal of equipment	-89	0	-20	-
Total costs and operating expenses	16,835	14,850	14,522	12,757
Income (loss) from operations	-276	185	-527	732
Other income, net	39	70	75	7
Income (loss) before provision for income taxes	-237	255	-452	739
Provision for income taxes	42	18	14	11
Net income (loss)	-	237	-466	-
Less net loss attributable to noncontrolling interest	-	-31	-30	-
Net income (loss) attributable to company's common shares	-279	268	-436	728

Basic EPS	-0.02	0.02	-0.03	0.05
Diluted EPS	-0.02	0.02	-0.03	0.05
Basic Average Shares	13,886,797	13,791,913	13,788,414	13,593,766
Diluted Average Shares	13,886,797	14,457,837	13,788,414	14,016,953

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.